| Abstrakt: |
Avava Inc. has been issued a patent for a feedback detection system for a treatment device. The patent focuses on the treatment of melasma, a common skin condition characterized by dark patches on the face. The inventors highlight the challenges of treating dermal melasma and the need for more effective and safe treatment options. The patent describes a method that involves converging electromagnetic radiation to a focal region in the skin, detecting the width of the radiation, determining a reference position, and translating the focal region to a treatment position. The inventors claim that this method can effectively target pigmented cells in the dermis while avoiding damage to healthy tissue. [Extracted from the article] |
